Introductory Clause Example with 24 Variations from Business Contracts

This page contains Introductory clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Introductory. Corvus Pharmaceuticals, Inc., a Delaware corporation ("Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), to issue and sell to the several Underwriters shares ("Firm Securities") of its common stock, par value $0.0001 per share ("Securities") and also proposes to issue and sell to the Underwriters, at the option of the Underwriters, a...n aggregate of not more than additional shares ("Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More
Found in Corvus Pharmaceuticals, Inc. contract

Variations of a "Introductory" Clause from Business Contracts

Introductory. Corvus Pharmaceuticals, Inc., a Delaware Energen Corporation, an Alabama corporation ("Company"), agrees with the several Underwriters named in Schedule A B hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), (the "Underwriters") to issue and sell to the several Underwriters 15,800,000 shares ("Firm Securities") of its common stock, par value $0.0001 $0.01 per share ("Securities") ("Securities"), and a...lso proposes to issue and sell to the several Underwriters, at the option of the Underwriters, an aggregate of not more than 2,370,000 additional shares ("Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". To the extent there are no additional Underwriters named in Schedule B other than you, the terms "Representative" and "Underwriters" as used herein shall mean Credit Suisse Securities (USA) LLC, as the sole Underwriter. View More
Found in Energen contract
Introductory. Corvus Pharmaceuticals, Inc., Synergy Resources Corporation, a Delaware Colorado corporation ("Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), ("Underwriters") to issue and sell to the several Underwriters 14,000,000 shares ("Firm Securities") of its common stock, par value $0.0001 $0.001 per share ("Securities") ("Securities"), an...d also proposes to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 2,100,000 additional shares ("Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More
Found in SRC Energy Inc. contract
Introductory. Corvus Pharmaceuticals, Inc., Performance Health Holdings Corp., a Delaware corporation ("Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), ("Underwriters") for whom Credit Suisse Securities (USA) LLC ("Credit Suisse") and Cowen and Company, Jefferies LLC ("Jefferies") are acting as representatives ("Representatives"), (in such capacity, the "Representatives") to issue and sell to the several Underwriters [·] shares ("Firm Securities") of its common sto...ck, par value $0.0001 per share ("Securities") and also proposes to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than [·] additional shares ("Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More
Found in PERFORMANCE HEALTH HOLDINGS CORP. contract
Introductory. Corvus Adamas Pharmaceuticals, Inc., a Delaware corporation ("Company"), (the "Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), (the "Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC Piper Jaffray & Co. are acting as representatives ("Representatives"), (the "Representatives"), to issue and sell to the several Underwriters [·] shares ("Firm (the "Firm Securities") of its common stock, $0.001 par value $0.0001 per s...hare ("Securities") (the "Securities") and also proposes to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than [·] additional shares ("Optional (the "Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More
Found in Adamas Pharmaceuticals Inc contract
Introductory. Corvus Pharmaceuticals, Upland Software, Inc., a Delaware corporation ("Company"), (the "Company") agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), (the "Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, Jefferies LLC are acting as representatives ("Representatives"), (in such capacity, the "Representatives") to issue and sell to the several Underwriters 3,300,000 shares ("Firm (the "Firm Securities") of its common stock, par valu...e $0.0001 per share ("Securities") and (the "Securities"). The Company also proposes agrees to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 495,000 additional shares ("Optional Securities") of its Securities as set forth below. ("Optional Securities"). The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More
Found in Upland Software, Inc. contract
Introductory. Corvus Pharmaceuticals, Inc., AK Steel Holding Corporation, a Delaware corporation ("Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), ("Underwriters") to issue and sell to the several Underwriters 65,000,000 shares ("Firm Securities") of its common stock, par value $0.0001 $0.01 per share ("Securities") ("Securities"), and also prop...oses to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 9,750,000 additional shares ("Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More
Found in AK Steel Holding Corp contract
Introductory. Corvus Pharmaceuticals, Inc., AK Steel Holding Corporation, a Delaware corporation ("Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), ("Underwriters") to issue and sell to the several Underwriters 52,000,000 shares ("Firm Securities") of its common stock, par value $0.0001 $0.01 per share ("Securities") ("Securities"), and also prop...oses to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 7,800,000 additional shares ("Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More
Found in AK Steel Holding Corp contract
Introductory. Corvus Pharmaceuticals, MyoKardia, Inc., a Delaware corporation ("Company"), (the "Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), (the "Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), (the "Representatives"), to issue and sell to the several Underwriters [ l ] shares ("Firm (the "Firm Securities") of its common stock, $0.0001 par value $0.0001 per share ("Securi...ties") (the "Securities") and also proposes to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than [ l ] additional shares ("Optional (the "Optional Securities") of its Securities as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More
Found in MyoKardia Inc contract
Introductory. Corvus Pharmaceuticals, Upland Software, Inc., a Delaware corporation ("Company"), (the "Company") agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), (the "Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), representative (in such capacity, the "Representative") to issue and sell to the several Underwriters 3,500,000 shares ("Firm (the "Firm Securities") of its common stock, par ...value $0.0001 per share ("Securities") and (the "Securities"). The Company also proposes agrees to issue and sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than 525,000 additional shares ("Optional Securities") of its Securities as set forth below. ("Optional Securities"). The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More
Found in Upland Software, Inc. contract
Introductory. Corvus Satsuma Pharmaceuticals, Inc., a Delaware corporation ("Company"), agrees with the several Underwriters named in Schedule A hereto ("Underwriters"), for whom Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as representatives ("Representatives"), ("Underwriters") to issue and sell to the several Underwriters [•] shares ("Firm Securities") of its common stock, par value $0.0001 per share ("Securities") and ("Securities"). The Company also proposes agrees to issue an...d sell to the Underwriters, at the option of the Underwriters, an aggregate of not more than [•] additional shares ("Optional Securities") of its Securities ("Optional Securities") as set forth below. The Firm Securities and the Optional Securities are herein collectively called the "Offered Securities". View More
Found in Satsuma Pharmaceuticals, Inc. contract